Botox News and Research

RSS
Botox is a drug made from a toxin produced by the bacterium Clostridium botulinum. It's the same toxin that causes a life-threatening type of food poisoning called botulism. Doctors use it in small doses to treat health problems, including, temporary removal of facial wrinkles, severe underarm sweating, cervical dystonia - a neurological disorder that causes severe neck and shoulder muscle contractions, blepharospasm - uncontrollable blinking, strabismus - misaligned eyes. Botox injections work by weakening or paralyzing certain muscles or by blocking certain nerves. The effects last about three to four months. Side effects can include pain at the injection site, flu-like symptoms, headache and upset stomach. Injections in the face may also cause temporary drooping eyelids. You should not use Botox if you are pregnant or breast feeding.
Kenneth D. Steinsapir receives rare USPTO patent for Microdroplet BOTOX

Kenneth D. Steinsapir receives rare USPTO patent for Microdroplet BOTOX

Spinal Botox injection reduces pain

Spinal Botox injection reduces pain

Blue Water Spa donates non-perishable food items to Interfaith Food Shuttle of NC

Blue Water Spa donates non-perishable food items to Interfaith Food Shuttle of NC

New York City surgeon performs first revision rhinoplasty cases with FDA approved PDS Plate

New York City surgeon performs first revision rhinoplasty cases with FDA approved PDS Plate

Study raises questions about therapeutic use of botulinum toxin A

Study raises questions about therapeutic use of botulinum toxin A

Botox Cosmetics increase overall quality of life and self-esteem

Botox Cosmetics increase overall quality of life and self-esteem

Winston announces Phase II study results of Dolorac for chronic migraine at Lazard Conference

Winston announces Phase II study results of Dolorac for chronic migraine at Lazard Conference

Alliance Data to provide private label credit services to American Laser Centers

Alliance Data to provide private label credit services to American Laser Centers

Merz to present data on Xeomin clinical studies for cervical dystonia at AAPM&R

Merz to present data on Xeomin clinical studies for cervical dystonia at AAPM&R

Allergan third quarter diluted loss per share increases to $2.21

Allergan third quarter diluted loss per share increases to $2.21

AZ-TMJ develops effective treatment for migraine headaches

AZ-TMJ develops effective treatment for migraine headaches

Botox beneficial for cosmetic dental treatment

Botox beneficial for cosmetic dental treatment

Botox receives FDA approval for treatment of chronic migraine

Botox receives FDA approval for treatment of chronic migraine

FDA approves BOTOX as prophylactic treatment for Chronic Migraine

FDA approves BOTOX as prophylactic treatment for Chronic Migraine

Sales of Merck's telcagepant and CoLucid's lasmiditan in world's major markets to reach $1.3 billion in 2019

Sales of Merck's telcagepant and CoLucid's lasmiditan in world's major markets to reach $1.3 billion in 2019

Xeomin botulinum toxin for cervical dystonia now available in the U.S.

Xeomin botulinum toxin for cervical dystonia now available in the U.S.

USPTO approves Microdroplet botulinum toxin treatment

USPTO approves Microdroplet botulinum toxin treatment

Warning on Australian clinics offering safe alternatives to mammograms

Warning on Australian clinics offering safe alternatives to mammograms

Johns Hopkins offers sources who can answer queries on prostrate cancer

Johns Hopkins offers sources who can answer queries on prostrate cancer

Botox maker agrees to pay $600 million for misbranding

Botox maker agrees to pay $600 million for misbranding